The Hau Giang Pharmaceutical Co (DHG) posted pre–tax profit of VND703.89 billion (US$6.7 million) in 2015, down about three per cent year-on-year. This was equal to achieving 96.56 per cent of the company's target.
DHG earned net profit of VND168.5 billion ($7.5 million) in the fourth quarter of 2015 alone, 40 per cent higher year-on-year.
DHG reported marked net revenue of VND3.6 trillion (VND160.82 million) in the fiscal year that ended on December 31, 2015, posting a year–on–year decrease of eight per cent. Of this figure, the company's net revenue in Q4 of 2015 reached VND1.149 trillion ($51.21 million), dropping 14 per cent year-on-year.
However, the company's sales expenses fell to touch VND151.2 billion ($6.7 million) in the fourth quarter of last year, 40 per cent lower year-on-year.
The company aims to earn VND3.7 trillion ($166.4 million) in revenue and VND750 billion ($33.4 million) in before-tax profit in 2016.